[Use of L-asparaginase in the treatment of patients with nephritis due to lupus: immediate and midterm effects].
D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000627:therapeutic use*; D001706:Biopsy; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009393:Nephritis / Q000188:drug therapy / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use
D001215:Asparaginase; D011241:Prednisone
Emprego da L-asparaginase na terapêutica de portadores de nefrite lúpica: efeitos imediatos e a médio prazo.